Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Other financing activities (2009 - 2022)

Icu Medical posted quarterly Other financing activities of $325000.0 for Q4 2022, down 82.45% on a QoQ basis from $1.9 million in Q1 2022.

Icu Medical (ICUI) has 9 years of Other financing activities data on file, last reported at $325000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $325000.0; the trailing twelve-month figure through Sep 2023 stood at $325000.0 (down 82.45% YoY), and the FY2025 full-year result was $2.8 million, changed N/A from the prior year.
  • Other financing activities for Q4 2022 stood at $325000.0, down from $1.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.9 million in Q1 2022 and bottomed at $325000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Icu Medical 3.25 Bn 2.96 Bn 206.23 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 325,000.00
Dec 31, 2022 325,000.00
Mar 31, 2022 1.85 Mn
Mar 31, 2022 1.85 Mn
Mar 31, 2016 2.51 Mn
Mar 31, 2016 2.51 Mn
Dec 31, 2015 3.14 Mn
Dec 31, 2015 3.14 Mn
Sep 30, 2015 2.77 Mn
Sep 30, 2015 2.77 Mn
Jun 30, 2015 366,000.00
Jun 30, 2015 366,000.00
Mar 31, 2015 3.06 Mn
Mar 31, 2015 3.06 Mn
Dec 31, 2014 2.97 Mn
Dec 31, 2014 2.97 Mn
Sep 30, 2014 749,000.00
Sep 30, 2014 749,000.00
Jun 30, 2014 807,000.00
Jun 30, 2014 807,000.00
Mar 31, 2014 1.18 Mn
Mar 31, 2014 1.18 Mn
Dec 31, 2013 2.40 Mn
Dec 31, 2013 2.40 Mn
Sep 30, 2013 1.48 Mn
Sep 30, 2013 1.48 Mn
Jun 30, 2013 2.05 Mn
Jun 30, 2013 2.05 Mn
Mar 31, 2013 1.03 Mn
Mar 31, 2013 1.03 Mn
Dec 31, 2012 565,000.00
Dec 31, 2012 565,000.00
Sep 30, 2012 1.24 Mn
Sep 30, 2012 1.24 Mn
Jun 30, 2012 1.13 Mn
Jun 30, 2012 1.13 Mn
Mar 31, 2012 1.63 Mn
Mar 31, 2012 1.63 Mn
Dec 31, 2011 606,000.00
Dec 31, 2011 606,000.00
Sep 30, 2011 965,000.00
Sep 30, 2011 965,000.00
Jun 30, 2011 2.44 Mn
Jun 30, 2011 2.44 Mn
Mar 31, 2011 280,000.00
Mar 31, 2011 280,000.00
Dec 31, 2010 972,000.00
Dec 31, 2010 972,000.00
Sep 30, 2010 650,000.00
Sep 30, 2010 650,000.00
Jun 30, 2010 29,000.00
Jun 30, 2010 29,000.00
Mar 31, 2010 29,000.00
Mar 31, 2010 29,000.00
Dec 31, 2009 13,000.00
Dec 31, 2009 13,000.00
Sep 30, 2009 40,000.00
Sep 30, 2009 40,000.00
Jun 30, 2009 29,000.00
Jun 30, 2009 29,000.00
Mar 31, 2009 19,000.00
Mar 31, 2009 19,000.00